Corline Biomedical AB (STO:CLBIO)

Corline Biomedical AB Ratios and Metrics

Market cap in millions SEK. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	447	189	320	198	314	249
Market Cap Growth	136.87%	-41.07%	61.60%	-36.85%	25.86%	-0.33%
Enterprise Value	441	181	303	169	271	241
Last Close Price	17.45	8.78	14.90	9.22	14.60	14.54
PE Ratio	-	-	-	85.08	-	-
Forward PE	-	13.41	3.90	-	-	-
PS Ratio	50.31	10.93	9.02	6.08	18.25	16.54
PB Ratio	5.79	2.17	3.43	2.10	3.40	4.79
P/TBV Ratio	5.79	2.17	3.43	2.10	3.40	4.79
P/FCF Ratio	-	-	424.69	-	-	-
P/OCF Ratio	-	-	361.41	-	-	-
EV/Sales Ratio	49.66	10.50	8.54	5.20	15.75	16.02
EV/EBITDA Ratio	-	-	-	71.03	-	-
EV/EBIT Ratio	-	-	-	72.74	-	-
EV/FCF Ratio	-26.32	-	402.14	-	-	-
Asset Turnover	0.10	0.18	0.35	0.32	0.22	0.25
Quick Ratio	1.32	2.59	3.28	4.82	4.71	1.66
Current Ratio	1.52	2.68	3.51	5.00	4.75	1.72
Return on Equity (ROE)	-29.49%	-25.74%	-1.93%	2.49%	-9.60%	-13.09%
Return on Assets (ROA)	-10.10%	-8.72%	-1.36%	1.43%	-5.40%	-7.46%
Return on Capital Employed (ROCE)	-18.30%	-15.60%	-2.40%	2.50%	-7.50%	-14.00%
Earnings Yield	-5.34%	-12.29%	-0.56%	1.18%	-2.21%	-2.92%
FCF Yield	-3.75%	-4.58%	0.24%	-3.33%	-1.59%	-2.05%
Buyback Yield / Dilution	-11.96%	-1.49%	2.19%	-7.50%	-22.58%	-2.46%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.